Home-Based Telehealth Exercise Intervention in Early-On Survivors of Childhood Acute Lymphoblastic Leukemia: Feasibility Study.
acute lymphoblastic leukemia
exercise therapy
intervention study
mobile phone
rehabilitation
telehealth
Journal
JMIR cancer
ISSN: 2369-1999
Titre abrégé: JMIR Cancer
Pays: Canada
ID NLM: 101666844
Informations de publication
Date de publication:
16 Jun 2021
16 Jun 2021
Historique:
received:
06
11
2020
accepted:
16
04
2021
revised:
12
02
2021
entrez:
16
6
2021
pubmed:
17
6
2021
medline:
17
6
2021
Statut:
epublish
Résumé
Acute lymphoblastic leukemia is the most common type of pediatric cancer. Acute lymphoblastic leukemia causes an altered bone mineral homeostasis state, which can contribute to osteopenia, and bone fractures, most commonly vertebral fractures. With the increasing number of childhood cancer survivors, late adverse effects such as musculoskeletal comorbidities are often reported and are further influenced by inactive lifestyle habits. Physical activity has been shown to increase the mechanical workload of the bone, mitigating bone impairment in other cancer-specific populations. This interventional pilot study aims to investigate the use of telehealth to deliver a home-based exercise intervention for early-on survivors of bone marrow-related hematological malignancies and to assess its impact on survivors' musculoskeletal and functional health. We aimed to recruit a group of 12 early-on survivors of acute lymphoblastic leukemia, within 6 months to 5 years of treatment, to participate in and complete the proposed telehealth intervention with a parent. The 16-week intervention included 40 potential home-based physical activity interventions supervised by a kinesiologist through a telehealth internet platform, with monthly progression. Patients were recruited to the cohort if they were able to participate in the intervention during the first month (minimum 12 weeks of intervention). Evaluation before and after the intervention protocol highlighted differences in functional capacities and musculoskeletal health of patients using mechanography, peripheral quantitative computed tomography, 6-minute walk test, and grip force test. The recruitment rate for the intervention was low (12/57, 21% of contacted patients). Of 12 patients, 3 were excluded (1=relapse, 1=failure to meet technical requirements, and 1=abandoned). The 9 patients who completed the intervention (6 girls; mean age 10.93, SD 2.83 years; mean BMI 21.58, SD 6.55 kg/m High adherence and participation rates suggest that telehealth is a feasible method to deliver exercise interventions to young early-on survivors of acute lymphoblastic leukemia. The proposed intervention seems promising in providing benefits to patients' functional performance and bone health, but a large-scale study is needed to confirm this assumption.
Sections du résumé
BACKGROUND
BACKGROUND
Acute lymphoblastic leukemia is the most common type of pediatric cancer. Acute lymphoblastic leukemia causes an altered bone mineral homeostasis state, which can contribute to osteopenia, and bone fractures, most commonly vertebral fractures. With the increasing number of childhood cancer survivors, late adverse effects such as musculoskeletal comorbidities are often reported and are further influenced by inactive lifestyle habits. Physical activity has been shown to increase the mechanical workload of the bone, mitigating bone impairment in other cancer-specific populations.
OBJECTIVE
OBJECTIVE
This interventional pilot study aims to investigate the use of telehealth to deliver a home-based exercise intervention for early-on survivors of bone marrow-related hematological malignancies and to assess its impact on survivors' musculoskeletal and functional health.
METHODS
METHODS
We aimed to recruit a group of 12 early-on survivors of acute lymphoblastic leukemia, within 6 months to 5 years of treatment, to participate in and complete the proposed telehealth intervention with a parent. The 16-week intervention included 40 potential home-based physical activity interventions supervised by a kinesiologist through a telehealth internet platform, with monthly progression. Patients were recruited to the cohort if they were able to participate in the intervention during the first month (minimum 12 weeks of intervention). Evaluation before and after the intervention protocol highlighted differences in functional capacities and musculoskeletal health of patients using mechanography, peripheral quantitative computed tomography, 6-minute walk test, and grip force test.
RESULTS
RESULTS
The recruitment rate for the intervention was low (12/57, 21% of contacted patients). Of 12 patients, 3 were excluded (1=relapse, 1=failure to meet technical requirements, and 1=abandoned). The 9 patients who completed the intervention (6 girls; mean age 10.93, SD 2.83 years; mean BMI 21.58, SD 6.55 kg/m
CONCLUSIONS
CONCLUSIONS
High adherence and participation rates suggest that telehealth is a feasible method to deliver exercise interventions to young early-on survivors of acute lymphoblastic leukemia. The proposed intervention seems promising in providing benefits to patients' functional performance and bone health, but a large-scale study is needed to confirm this assumption.
Identifiants
pubmed: 34132645
pii: v7i2e25569
doi: 10.2196/25569
pmc: PMC8277387
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e25569Informations de copyright
©Genevieve Lambert, Nathalie Alos, Pascal Bernier, Caroline Laverdière, Dahlia Kairy, Kenneth Drummond, Noémi Dahan-Oliel, Martin Lemay, Louis-Nicolas Veilleux. Originally published in JMIR Cancer (https://cancer.jmir.org), 16.06.2021.
Références
Anat Rec A Discov Mol Cell Evol Biol. 2003 Dec;275(2):1081-101
pubmed: 14613308
Med Sci Sports Exerc. 2004 Apr;36(4):674-88
pubmed: 15064596
Pediatr Blood Cancer. 2009 Jul;53(1):64-71
pubmed: 19283791
J Musculoskelet Neuronal Interact. 2010 Dec;10(4):256-66
pubmed: 21116062
Pediatr Blood Cancer. 2008 Feb;50(2 Suppl):456-61; discussion 468
pubmed: 18064643
Bone. 2020 May;134:115261
pubmed: 32028018
Calcif Tissue Int. 2014 Feb;94(2):202-11
pubmed: 24077875
Ann Behav Med. 2005 Apr;29 Suppl:20-8
pubmed: 15921486
Rehabil Nurs. 2013 Jan-Feb;38(1):48-59
pubmed: 23365005
J Bone Miner Res. 2014 Feb;29(2):467-78
pubmed: 23857721
Eur J Cancer Care (Engl). 2016 Nov;25(6):1034-1043
pubmed: 27647691
J Clin Endocrinol Metab. 2013 May;98(5):E990-5
pubmed: 23526465
Health Rep. 2016 Oct 19;27(10):3-10
pubmed: 27759870
Leuk Lymphoma. 2019 Dec;60(13):3146-3153
pubmed: 31264493
Int J Endocrinol Metab. 2012 Spring;10(2):486-9
pubmed: 23843808
Cancer Nurs. 2013 Sep-Oct;36(5):E9-E16
pubmed: 23963198
Bone. 2000 Aug;27(2):319-26
pubmed: 10913929
Pain. 2019 Jan;160(1):5-18
pubmed: 30180088
Osteoporos Int. 2018 Feb;29(2):287-303
pubmed: 28971226
Pediatr Blood Cancer. 2014 Aug;61(8):1451-6
pubmed: 24648266
Eur J Cancer. 1999 Nov;35(12):1693-7
pubmed: 10674015
Pediatr Blood Cancer. 2004 Feb;42(2):127-33
pubmed: 14752875
J Pediatr Hematol Oncol. 2020 Jan;42(1):53-60
pubmed: 31568179
PM R. 2017 Sep;9(9S2):S347-S384
pubmed: 28942909
J Bone Miner Res. 2009 Jul;24(7):1326-34
pubmed: 19210218
Disabil Rehabil. 2020 Feb 11;:1-8
pubmed: 32045540
Support Care Cancer. 2018 Jul;26(7):2177-2184
pubmed: 29383508
BMC Pulm Med. 2013 Aug 05;13:49
pubmed: 23915140
Pediatr Phys Ther. 2014 Fall;26(3):301-7
pubmed: 24979081
Cancer. 2018 Mar 15;124(6):1225-1231
pubmed: 29231963
Support Care Cancer. 2020 Jul;28(7):3171-3178
pubmed: 31707503
Pediatr Blood Cancer. 2017 Sep;64(9):
pubmed: 28233475
Physiother Res Int. 2009 Jun;14(2):91-104
pubmed: 19003813
Bone. 2016 Apr;85:131-7
pubmed: 26851412
Oncologist. 2001;6(3):278-85
pubmed: 11423675
JMIR Mhealth Uhealth. 2018 Mar 01;6(3):e47
pubmed: 29496655
J Clin Endocrinol Metab. 2014 Feb;99(2):E356-62
pubmed: 24248189
J Sport Rehabil. 2012 Feb;21(1):18-25
pubmed: 22100700
Physiother Can. 2015 Aug;67(3):292-9
pubmed: 26839461
Med Sci Sports Exerc. 2011 Nov;43(11):2102-9
pubmed: 21502901
Med Pediatr Oncol. 2003 Apr;40(4):230-2
pubmed: 12555250
J Clin Oncol. 2012 Aug 1;30(22):2760-7
pubmed: 22734031
Physiotherapy. 2018 Sep;104(3):277-298
pubmed: 30030037
Horm Res Paediatr. 2019;91(2):137-151
pubmed: 30481777
Int J Cancer Suppl. 1998;11:35-9
pubmed: 9876475
Bone. 2015 Oct;79:52-7
pubmed: 26004918
Support Care Cancer. 2021 Feb;29(2):551-554
pubmed: 32918606
Int J Cancer. 2020 Aug 1;147(3):847-855
pubmed: 31800093
J Telemed Telecare. 2020 Dec;26(10):581-589
pubmed: 31213166
Eur Respir J. 2005 Jun;25(6):1057-60
pubmed: 15929962